The UK Competition Authority issues a provisional decision on remedies to increase competition in the private healthcare market (HCA)

CMA’s private healthcare provisional decision on remedies* The CMA has provisionally found that likely changes in London’s private healthcare market mean that extra remedies would not be proportionate. In April 2012, the Competition Commission, a predecessor body of the Competition and Markets Authority (CMA), started a market investigation into private healthcare which reported in April 2014, immediately after the establishment of the CMA. The report concluded that certain features of the markets for privately-funded healthcare services were leading to an adverse effect on competition (AEC). A

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • United Kingdom’s Competition Authority - CMA (London)

Quotation

UK Competition Authority, The UK Competition Authority issues a provisional decision on remedies to increase competition in the private healthcare market (HCA), 22 March 2016, e-Competitions Notion of dominance, Art. N° 78818

Visites 239

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues